Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00945100 · ClinicalTrials.gov registry record · Phase 3
Increasing Patching for Amblyopia in Children 3 to < 8 Years Old
A Phase 3 study, sponsored by Jaeb Center for Health Research.
- Completed
- Registry status
- Phase 3
- Development phase
- 169
- Enrollment target
NCT00945100 is a Phase 3 study that has completed, run by Jaeb Center for Health Research. The registered enrollment target is 169 participants.
The verdict
NCT00945100, a Phase 3 study, has completed, sponsored by Jaeb Center for Health Research.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 169 participants
- Enrollment target
Study Summary
This study is designed to evaluate the effectiveness of increasing prescribed patching treatment from 2 to 6 daily hours after visual acuity has stabilized with initial treatment and amblyopia is still present. Children ages 3 to \<8 years with visual acuity of 20/50 to 20/400 in the amblyopic eye will be enrolled in a run-in phase with 2 hours daily patching until no improvement, followed by randomization of eligible patients to patching 2 hours daily versus an average of 6 hours daily (42 hours per week). The primary objective is to determine if increasing patching dosage will improve visual acuity in patients with amblyopia still present after visual acuity has stabilized with initial treatment.
Interventions
- DEVICE Eye Patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 169 participants |
| Start Date | 2009-08 |
| Est. Completion | 2013-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00945100
The ClinicalTrials.gov registry entry for NCT00945100 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 169 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jaeb Center for Health Research, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Eye Patch is the first listed.
NCT00945100 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00945100 about?
NCT00945100 is a clinical study titled "Increasing Patching for Amblyopia in Children 3 to < 8 Years Old". This study is designed to evaluate the effectiveness of increasing prescribed patching treatment from 2 to 6 daily hours after visual acuity has stabilized with initial treatment and amblyopia is still present. Children ages 3 to \<8 years with visual acuity of 20/50 to 20/400 in the amblyopic eye w...
What is the current status of trial NCT00945100?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 169 participants. The study started on 2009-08. Estimated completion is 2013-03.
What interventions are being tested in trial NCT00945100?
The interventions under investigation include: Eye Patch (DEVICE).
Who is sponsoring clinical trial NCT00945100?
This trial is sponsored by Jaeb Center for Health Research, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.